Stock Market & Financial Investment News

News Breaks October 2, 2012 08:33 EDT COV Covidien pharmaceutical business completes acquisition of CNS Therapeutics Mallinckrodt, the Pharmaceuticals business of Covidien, announced that it has completed its acquisition of CNS Therapeutics for approximately $100M. CNS is a privately held specialty pharmaceuticals company focused on developing and commercializing products for site-specific administration to the central nervous system to treat neurological disorders and intractable chronic pain. Covidien does not expect this transaction to have a material impact on its fiscal 2013 sales or earnings per share. Covidien will report the CNS Therapeutics business in the Specialty Pharmaceuticals product line within the Pharmaceuticals segment. News For COV From The Last 14 Days Check below for free stories on COV the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 16, 2013 07:28 EDT COV I/O Central to host a conference Subscribe for More Information May 10, 2013 06:16 EDT COV Obesity surgery booming in India, Bloomberg reports Subscribe for More Information May 8, 2013 07:38 EDT COV BofA/Merrill's medical tech analyst hold an analyst/industry conference call Subscribe for More Information May 7, 2013 07:24 EDT COV Mizuho Securities to host a conference Subscribe for More Information May 6, 2013 07:18 EDT COV American Congress of Obstetrics and Gynecology to hold annual meeting Subscribe for More Information 05:57 EDT COV Covidien to host conference call Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.